Hand, foot, and mouth disease can be a stressful experience for parents when their children fall ill. A large review of clinical trials involving over 36,000 children looked at how well an inactivated EV-A71 vaccine protects against this specific virus.
The data shows the vaccine is highly effective, with a success rate of over 98% in preventing cases caused by the EV-A71 virus. The study also found that children who received the vaccine showed much higher levels of antibodies early on and maintained those levels over the medium and long term.
Safety was another key focus for the researchers. They found that local and systemic side effects were mild, and the vaccine was well tolerated by the children compared to those who received a placebo. While these results are very promising for protecting children from this virus, always talk to your doctor about the best vaccination schedule for your child.
